RareResearch.AI
← Back to atlas

K482R

AlphaMissense: likely benign (0.07)Uncertain significanceTransmembrane · predicted
LysineArginine at position 482 · Transmembrane helix 6 · WFS1 (Wolframin)

Interactive 3D Structure

Interactive structure
rotate · zoom · variant + 5 Å neighbors
Fullscreen ↗

Computational Predictions

AlphaMissense
0.072
likely benign
AlphaFold pLDDT
68
model confidence
DynaMut2 ΔΔG
pending
not yet computed
ClinVar
Uncertain significance
Uncertain significance

AlphaMissense + AlphaFold card. This variant is mapped from AlphaMissense pathogenicity and AlphaFold confidence. The DynaMut2 ΔΔG stability prediction and the wild-type/mutant structural comparison (dual-pane + bond network) are computed per-variant and backfill here — they require a DynaMut2 submission, unlike the precomputed AlphaMissense score.

Clinical Evidence

ClinVar classificationUncertain significance
Review statusno assertion criteria provided
Associated conditionsRetinal dystrophy
Population frequency (gnomAD v4)Ultra-rare · AF 0.00055%
cDNA changec.1445A>G
ClinVar accessionVCV003249354
Last evaluated2022/01/01 00:00

Observed at very low frequency in gnomAD.

Classified for0★ unverified submission

ClinVar classifies this variant as Uncertain significance for Retinal dystrophy (inheritance not specified).

  • Retinal dystrophyinheritance not specifiedsubmitted as: Retinal dystrophy
  • No assertion criteria were provided (0★). Treat the conditions above as unverified submissions, not as documented phenotypes.
  • Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient.
  • Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

Review status: 0★ no assertion criteria provided. ClinVar "conditions" is the union of all submissions; 0–1★ entries are submitted conditions, not documented phenotypes.

Population frequency
Global (all ancestries)
AF 0.00055% · 8 / 1,459,326 alleles
Homozygotes
0
Highest-frequency population
European (non-Finnish) · AF 0.00063%

Highest in European (non-Finnish): AF 0.00063% (7 of 1,111,992 alleles), in line with the global figure.

No homozygotes reported in gnomAD v4. For a recessive allele this is expected and is not, on its own, evidence either way.

Ancestry groupAllele freq.AC / ANHom.Carrier est.
African / African American · under-sampled0.0030%1 / 33,4780
European (non-Finnish)0.00063%7 / 1,111,9920~1 in 79430

Source: gnomAD r4, retrieved 2026-08-21. Values are allele frequencies. The carrier estimate is derived from the allele frequency (Hardy-Weinberg, ~2·AF) and is an approximation, not a published figure — where a published carrier frequency exists it outranks this column and is cited on the card.

Full Variant Card

K482R — WFS1 Molecular Atlas Card

Variant type: Missense Substitution: Lysine (K) → Arginine (R) at position 482 Domain context: Transmembrane helix 6


AlphaMissense

  • Pathogenicity score: 0.0723
  • Class: likely benign

AlphaFold confidence

  • pLDDT at residue 482: 68.12

DynaMut2 ΔΔG: not yet computed for this variant — AlphaMissense + AlphaFold confidence shown above. Stability ΔΔG and the wild-type/mutant structural comparison backfill behind this note.


Clinical evidence

Inheritance and scope

Uncertain significance — for Retinal dystrophy (inheritance not specified)

ClinVar classifies this variant as Uncertain significance for Retinal dystrophy (inheritance not specified).

No assertion criteria were provided (0★). Treat the conditions above as unverified submissions, not as documented phenotypes. Phenotype scope is interpretation of submitted records. The computed values on this card (AlphaMissense, DynaMut2 ΔΔG, pLDDT) are measurements of the model, not of a patient. Presentation cannot be generalised from neighbouring variants: one nucleotide over can present very differently. Structural similarity supports a mechanistic hypothesis, never a phenotype claim.

  • Classification: Uncertain significance
  • Review status: no assertion criteria provided
  • Associated conditions: Retinal dystrophy
  • cDNA change: c.1445A>G
  • ClinVar accession: VCV003249354
  • Last evaluated: 2022/01/01 00:00
  • Submissions: 1

Card generated by wolfram-atlas-batch (missense AlphaMissense mint) on 2026-06-08T02:27:33.567040Z. AlphaMissense (Cheng et al. 2023) · AlphaFold model v6 · UniProt O76024.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the K482R PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download K482R PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.